NP / PA
Allergy, Asthma & Immunology Associates of South Texas, P.A.
Allergy, Asthma & Immunology Associates of South Texas, P.A. was paid $8.85M by Medicaid between Jun 2019 and Dec 2024, across 35 billing codes. Its largest line is J2357, Injection, omalizumab, 5 mg — 47% of everything it billed.
33Billing provider infoALLERGY, ASTHMA & IMMUNOLOGY ASSOCIATES OF SOUTH TEXAS, P.A.
SAN ANTONIO, TX 78229
SAN ANTONIO, TX 78229
33aNPI1023175239assigned 01/03/2007
33bProvider typePhysician Assistant
28Total paid$8.85M
24GClaims117,687
24DCodes billed35
24AFirst – last monthJun 2019 – Dec 2024
Compared with peers
Next to other Physician Assistant providers in Texas
Rank by total paid#7 of 161
Median peer was paid$43K
This provider vs. median205×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 129 | $976.16 | |
| 2020 | 4,465 | $386K | |
| 2021 | 34,517 | $2.47M | |
| 2022 | 34,128 | $2.62M | |
| 2023 | 28,013 | $2.31M | |
| 2024incomplete | 16,435 | $1.06M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | 47% | 2,141 | 1,505 | $4.17M |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 14% | 5,219 | 1,975 | $1.28M |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 12% | 4,377 | 4,280 | $1.02M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.2% | 15,101 | 14,574 | $729K |
| 96401 | 4.5% | 3,735 | 2,768 | $401K | |
| 95117 | 2.9% | 24,832 | 13,268 | $256K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 2.2% | 1,609 | 1,583 | $194K |
| 94375 | 1.7% | 5,089 | 4,927 | $152K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.6% | 1,762 | 1,732 | $140K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.3% | 3,324 | 3,265 | $114K |
| 94010 | <1% | 3,132 | 3,003 | $75K | |
| 70486 | <1% | 516 | 499 | $66K |
23 more codes
| 95012 | <1% | 3,573 | $50K | |
| 95115 | <1% | 5,896 | $50K | |
| 94060 | <1% | 815 | $33K | |
| A7016 | Dome and mouthpiece, used with small volume ultrasonic nebulizer | <1% | 7,334 | $23K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,830 | $21K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 210 | $16K |
| 99245 | <1% | 91 | $14K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,303 | $14K |
| 99243 | <1% | 85 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 775 | $5K |
| 94760 | <1% | 9,141 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 49 | $3K |
| 0001A | <1% | 43 | $2K | |
| 0002A | <1% | 42 | $2K | |
| A4208 | Syringe with needle, sterile 3 cc, each | <1% | 3,555 | $2K |
| 99358 | Prolong nursin fac eval 15m | <1% | 26 | $1K |
| 99205 | Prolong outpt/office vis | <1% | 13 | $1K |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 755 | $907.46 |
| 94664 | <1% | 7,819 | $147.26 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 905 | $27.09 |
| 96160 | <1% | 805 | $22.77 | |
| J3590 | Unclassified biologics | <1% | 1,684 | $0.06 |
| 91300 | 0% | 101 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCSCHEVA-JOHNSON, TATIANA (CHIEF HUMAN RESOURCE OFFICER)